J.P. Morgan Healthcare Conference

Taking place in San Francisco in mid-January, it anchors “JPM Week,” when a wide ecosystem of healthcare partnering meetings and satellite events run in parallel across the city.

Who the audience is and how many attend

Audience

• Public and private biopharma, medtech, diagnostics and health tech leadership teams
• Institutional investors, analysts and bankers focused on healthcare
• Emerging companies seeking financing and strategic partners
• Professional services and solution providers supporting healthcare dealmaking

Scale

• The conference is widely regarded as one of the industry’s largest healthcare investment gatherings.
• Reported attendance is commonly cited at 8,000+ participants for the core conference, with significantly larger numbers participating in the broader “JPM Week” ecosystem in San Francisco.

What to expect

• High-profile company presentations and investor-facing updates across biopharma, medtech and health tech
• Dealmaking-oriented networking and a packed calendar of side meetings during JPM Week
• Market, capital and M&A sentiment-setting conversations that often influence healthcare narratives early in the year
• A fast-paced, senior audience and agenda built around finance, partnerships and strategic positioningThe Conference is the industry’s biggest gathering, bringing together more than 8,000 investors, industry professionals, senior government officials and 550 global health care companies — ranging from Fortune 100 corporations to small-cap and emerging private companies — to discuss the latest market trends and medical innovations.